Portfolio company
Deep Blue BioTech
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company uses cyanobacteria technology to produce chemicals from carbon dioxide for the pharmaceutical, beauty, and personal care industries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CyanoCapture
The company provides genetically engineered cyanobacteria to industrial emitters and pharmaceutical firms for carbon capture and the synthesis of high-value biomolecules.
Origin by Ocean
This company produces algae-derived biochemical ingredients for international manufacturers in the cosmetics, food, textile, and pharmaceutical industries.
Aura Life Science
This company develops a photosynthetic biomanufacturing platform using engineered cyanobacteria to produce proteins and enzymes for industrial, food, and pharmaceutical customers.
SOLMEYEA
The company produces microalgae-based proteins and ingredients from captured carbon dioxide for food, cosmetic and biofuel manufacturers.
Cyanotype Bio
The company develops an artificial intelligence platform for discovering and manufacturing plant-based bioactives for the biotechnology and environmental research industries.
Neo Earth
This company develops high-yield natural microalgae strains and cultivation systems for global producers in the food, cosmetics, nutraceutical and animal feed sectors.
BlueCell Bio
BlueCell Bio develops fermentation technologies to produce bioavailable microalgae ingredients for the human nutrition, animal feed and pet food industries.
CarbonBridge
This company develops bioreactors that use microbes to convert waste greenhouse gases into methanol for maritime fuel and industrial chemical customers.